BACKGROUND: The development of invasive Haemophilus influenzae serotype b (Hib) disease after prior immunization with the Hib conjugate vaccine (ie, Hib vaccine failure) is extremely rare, suggesting that affected children may have an underlying genetic susceptibility in their immune response. The objective of this study was to investigate single-nucleotide polymorphisms (SNPs) known to affect function in biologically plausible genes in relation to the risk of Hib vaccine failure and its clinical manifestations. METHODS: The families of UK children with Hib vaccine failure diagnosed during the period October 1992 through December 2005 were identified through enhanced national surveillance and approached for the study at a median interval of...
The aim of the Malmö International Brother Study (MIBS) is to evaluate host genetic factors associat...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
It is well documented that 5-10% hepatitis B adult vaccinees are non- and hypo-responders and probab...
BACKGROUND: The development of invasive Haemophilus influenzae serotype b (Hib) disease after prior ...
Vaccines have had a profound influence on human health with no other health intervention rivalling t...
The immune response to hepatitis B vaccination differs greatly among individuals, with 5-10% of heal...
Vaccines have revolutionized public health, preventing millions of deaths each year, particularly in...
Vaccines have revolutionized public health, preventing millions of deaths each year, particularly in...
A bstract. In experimental animals, immune responses to certain antigens are regulated by immuno-glo...
Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
Before the introduction of the conjugate vaccine, Haemophilus influenzae serotype b (Hib) was the le...
Despite the success of vaccines in routine use worldwide, there are substantial challenges hampering...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
The aim of the Malmö International Brother Study (MIBS) is to evaluate host genetic factors associat...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
It is well documented that 5-10% hepatitis B adult vaccinees are non- and hypo-responders and probab...
BACKGROUND: The development of invasive Haemophilus influenzae serotype b (Hib) disease after prior ...
Vaccines have had a profound influence on human health with no other health intervention rivalling t...
The immune response to hepatitis B vaccination differs greatly among individuals, with 5-10% of heal...
Vaccines have revolutionized public health, preventing millions of deaths each year, particularly in...
Vaccines have revolutionized public health, preventing millions of deaths each year, particularly in...
A bstract. In experimental animals, immune responses to certain antigens are regulated by immuno-glo...
Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, va...
Before the introduction of the conjugate vaccine, Haemophilus influenzae serotype b (Hib) was the le...
Despite the success of vaccines in routine use worldwide, there are substantial challenges hampering...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induce...
The aim of the Malmö International Brother Study (MIBS) is to evaluate host genetic factors associat...
Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines ...
It is well documented that 5-10% hepatitis B adult vaccinees are non- and hypo-responders and probab...